Gilead Sciences (GILD) call put ratio 2.3 calls to 1 put after FT says remdesivir failed in first trial
Go back to Gilead Sciences (GILD) call put ratio 2.3 calls to 1 put after FT says remdesivir failed in first trial| Gilead Sciences (NASDAQ: GILD) | Delayed: 146.64 -4.35 (2.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.99 | 52 Week High | $108.63 | |||
| Open | $146.98 | 52 Week Low | $71.39 | |||
| Day High | $148.65 | P/E | 81.02 | |||
| Day Low | $145.45 | EPS | $1.81 | |||
| Volume | 6,080,505 | |||||
